199 related articles for article (PubMed ID: 6482725)
1. [Epidemiologic study of 2 foci of Schistosoma mansoni bilharziasis in Togo (Lama Kara and Kpalimé). Comparative efficacy of oltipraz (RP 35972)].
Lapierre J; Amedome A; Tourte-Schaefer C; Agbo K; Kotor T; Faurant C; Ancelle T; Heyer F; Dupouy-Camet J
Med Trop (Mars); 1984; 44(2):113-9. PubMed ID: 6482725
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 700 cases of bilharziasis with the new drugs oxamniquine, oltipraz, praziquantel].
Lapierre J; Keita A; Faurant C; Heyer F; Tourte-Schaefer C; Ancelle T; Dupouy-Camet J
Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):526-33. PubMed ID: 6673843
[TBL] [Abstract][Full Text] [Related]
3. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
Katz N; Rocha RS; Chaves A
Rev Inst Med Trop Sao Paulo; 1982; 24(1):40-8. PubMed ID: 6750759
[No Abstract] [Full Text] [Related]
4. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
[No Abstract] [Full Text] [Related]
5. [Complement to the epidemiologic study of the focus of Schistosoma mansoni bilharziasis in Kara (northern Togo)].
Lapierre J; Tourte-Schaefer C; Dupouy-Camet J; Cot M; Heyer F; Faurant C
Bull Soc Pathol Exot; 1992; 85(3):232-7. PubMed ID: 1422275
[TBL] [Abstract][Full Text] [Related]
6. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni, and Schistosoma intercalatum.
Gentilini M; Duflo B; Richard-Lenoble D; Brücker G; Danis M; Niel G; Meunier Y
Acta Trop; 1980 Sep; 37(3):271-4. PubMed ID: 6106367
[No Abstract] [Full Text] [Related]
7. [Therapy of Schistosoma mansoni bilharziasis with RP. 35972 (Oltipraz). Preliminary results of initial therapy in Madagascar].
Cerf P; Moyroud J; Coulanges P
Arch Inst Pasteur Madagascar; 1981; 48(1):163-8. PubMed ID: 7342892
[No Abstract] [Full Text] [Related]
8. [An epidemiologic study of a focus of Schistosoma mansoni bilharziasis in Kara (North Togo)].
Lapierre J; Tourte-Schaefer C; Dupouy-Camet J; Heyer F; Faurant C
Bull Soc Pathol Exot Filiales; 1988; 81(5):861-8. PubMed ID: 3149219
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
Queinnec J; Moyroud J
Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
[No Abstract] [Full Text] [Related]
10. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
[No Abstract] [Full Text] [Related]
11. [The treatment of Schistosomiasis mansoni with RP 35972 (Oltipraz). Preliminary results (author's transl)].
Cerf P; Moyroud J; Coulanges P
Bull Soc Pathol Exot Filiales; 1982; 75(2):174-8. PubMed ID: 7105289
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of UK 4271 (oxamniquine, Pfizer) in Schistosoma mansoni bilharziasis in western Africa (parasitological and serological study of 252 children)].
Nozais JP; Geunier M
Bull Soc Pathol Exot Filiales; 1979; 72(2):153-64. PubMed ID: 527159
[TBL] [Abstract][Full Text] [Related]
13. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
[No Abstract] [Full Text] [Related]
14. [Treatment of bilharziasis in Madagascar. Use of oltipraz in mass campaign against S. mansoni and S. haematobium].
Moyroud J; Breuil J; Coulanges P; Charmot G
Nouv Presse Med; 1982 Dec; 11(50):3732. PubMed ID: 7170183
[No Abstract] [Full Text] [Related]
15. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
[No Abstract] [Full Text] [Related]
16. [Oxamniquine in the treatment of Schistosoma mansoni infection].
Kapend'a K; Odio W; Toko AL; Vandepitte J; Kayembe NN; Wane J
Ann Soc Belg Med Trop; 1982; 62(3):213-9. PubMed ID: 7181541
[No Abstract] [Full Text] [Related]
17. Oxamniquine in the treatment of schistosomiasis in a population in area with low endemicity.
Bina JC; Prata A
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):94-7, 212-6. PubMed ID: 7455516
[No Abstract] [Full Text] [Related]
18. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
Rugemalila JB; Asila J; Chimbe A
J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
Gupta KK
East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
[No Abstract] [Full Text] [Related]
20. Quantitation of immunoglobulins in patients with schistosomiasis mansoni under chemotherapy.
Mendes CM; Carvalho SA; Amato Neto V; Novo NF; Juliano Y; Mendes E
Allergol Immunopathol (Madr); 1982; 10(2):105-8. PubMed ID: 7102486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
